Wnt family ligands

VT104 is a potent and orally active YAP/TAZ inhibitor. VT104 prevents palmitoylation of endogenous TEAD1 and TEAD3 proteins. VT104 can be used in research of cancer.In VitroVT104 (0-1000 nM) inhibits proliferation of NF2 mutant/defective cell line.

VT-107, as an analogous to VT104, is an orally active and potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancerIn VitroVT107 (3 μmol/L 20 hours HEK293T cells) inhibits palmitoylation of both endogenous TEAD1

VT-107, as an analogous to VT104, is an orally active and potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancerIn VitroVT107 (3 μmol/L 20 hours HEK293T cells) inhibits palmitoylation of both endogenous TEAD1

VT-107, as an analogous to VT104, is an orally active and potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancerIn VitroVT107 (3 μmol/L 20 hours HEK293T cells) inhibits palmitoylation of both endogenous TEAD1

VT-107, as an analogous to VT104, is an orally active and potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancerIn VitroVT107 (3 μmol/L 20 hours HEK293T cells) inhibits palmitoylation of both endogenous TEAD1

W1131 is a potent STAT3 inhibitor, triggering ferroptosis. W1131 suppresses cancer progression in gastric cancer cell subcutaneous xenograft model, organoids model, and PDX model. W1131 effectively alleviates chemical resistance of cancer cells to

W1131 is a potent STAT3 inhibitor, triggering ferroptosis. W1131 suppresses cancer progression in gastric cancer cell subcutaneous xenograft model, organoids model, and PDX model. W1131 effectively alleviates chemical resistance of cancer cells to

W1131 is a potent STAT3 inhibitor, triggering ferroptosis. W1131 suppresses cancer progression in gastric cancer cell subcutaneous xenograft model, organoids model, and PDX model. W1131 effectively alleviates chemical resistance of cancer cells to

W1131 is a potent STAT3 inhibitor, triggering ferroptosis. W1131 suppresses cancer progression in gastric cancer cell subcutaneous xenograft model, organoids model, and PDX model. W1131 effectively alleviates chemical resistance of cancer cells to

Warangalone is an anti-malarial compound which can inhibit the growth of both strains of parasite 3D7 (chloroquine sensitive) and K1 (chloroquine resistant) with IC 50 s of 4.8 μg/mL and 3.7 μg/mL, respectively. Warangalone can also inhibit cyclic

WIC1 is a potent Wnt inhibitor. WIC1 can be used for the research of cancer.In VitroWICl (10 nM, 100 nM, 10μM, 100 μM) decrease TFC/LEF luciferase reporter activity in BEAS2B cell. WICl (10 nM, 100 nM, 10μM, 100 μM) shows minimal toxicity./nWICl

WIC1 is a potent Wnt inhibitor. WIC1 can be used for the research of cancer.In VitroWICl (10 nM, 100 nM, 10μM, 100 μM) decrease TFC/LEF luciferase reporter activity in BEAS2B cell. WICl (10 nM, 100 nM, 10μM, 100 μM) shows minimal toxicity./nWICl